Today: 1 May 2026
Rocket Lab stock slips after COO’s $7.3 million sale filing; RKLB focus shifts to earnings
7 January 2026
1 min read

Rocket Lab stock slips after COO’s $7.3 million sale filing; RKLB focus shifts to earnings

New York, Jan 7, 2026, 16:55 EST — After-hours

  • Rocket Lab shares fell 2.2% in regular trade after an executive stock sale disclosure
  • SEC filing showed the COO sold 100,000 shares under a pre-set trading plan
  • Investors now eye the next earnings update and any Neutron timeline signals

Rocket Lab Corp shares closed down 2.2% at $84.16 on Wednesday, after swinging between $81.85 and $85.96 as investors digested an insider sale after a sharp run-up earlier this week.

The pullback matters because Rocket Lab has become a crowded trade in space-and-defense stocks, where price moves have been fast and explanations thin. After a big early-January jump, traders have been quick to treat insider selling as a check on momentum, even when it is routine.

A filing with the U.S. Securities and Exchange Commission showed Chief Operating Officer Frank Klein sold 100,000 shares on Jan. 2 at weighted average prices from $67.61 to $75.80, for proceeds of about $7.3 million. The filing said the sales were made under a Rule 10b5-1 plan — a pre-arranged trading plan companies use to reduce the risk of trading on inside information — and that Klein held 1,169,487 shares after the transactions.

The broader tape was mixed. The S&P 500 slipped 0.3% and the Dow fell 0.9% on Wednesday, while the Nasdaq edged higher, leaving some high-beta names without much index help.

Rocket Lab’s stock has been buoyed in recent weeks by defense-related optimism, including a Space Development Agency award the company disclosed in December. In an 8-K, Rocket Lab said the SDA contract has a total value of $816 million, including a $806 million base amount and options of about $10 million, with final delivery of the satellites expected in 2029.

Still, there’s a simple risk case: insider selling can persist, and contract work and rocket development do not always land on clean schedules. Any slip in major program milestones — or signs costs are rising faster than revenue — can hit a stock that has been trading near recent highs.

What’s next is the calendar. Rocket Lab is expected to report results on Feb. 26, according to Nasdaq’s earnings schedule, and investors will listen for updates on margins, backlog conversion and any shifts in timelines for its next-generation Neutron rocket.

Stock Market Today

  • Avalyn Pharma Rings Nasdaq Opening Bell Highlighting Pulmonary Fibrosis Treatment Advances
    April 30, 2026, 6:32 PM EDT. Avalyn Pharma (Nasdaq: AVLN) marked a milestone by ringing the Opening Bell at Nasdaq MarketSite in Times Square. CEO Lyn Baranowski led the ceremony, spotlighting the company's efforts to develop optimized inhaled formulations of antifibrotic drugs. These medicines target pulmonary fibrosis, a rare and serious respiratory disease. Avalyn aims to transform treatment paradigms with these innovations. The event underscores Avalyn's focus on rare lung conditions and growing presence in the biotech sector.

Latest article

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

30 April 2026
Nvidia shares dropped 4.6% to $199.57 Thursday as investors reacted to Alphabet and Amazon expanding sales of their own AI chips. Alphabet reported Google Cloud revenue up 63% and began selling TPU chips directly to customers. AMD and Broadcom shares rose 5.1% and 3.0%, respectively. Amazon said its Trainium chip line secured $225 billion in revenue commitments.
AMD stock slips after hours as CES AI chip blitz sets up Feb. 3 earnings test
Previous Story

AMD stock slips after hours as CES AI chip blitz sets up Feb. 3 earnings test

JPMorgan set to take over Apple Card from Goldman in $20 billion switch
Next Story

JPMorgan set to take over Apple Card from Goldman in $20 billion switch

Go toTop